Inovio director granted RSUs and stock options
INOVIO PHARMACEUTICALS, INC. director Ann Calby Miller received new equity awards as part of non-employee director compensation.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
INOVIO PHARMACEUTICALS, INC. director Ann Calby Miller received new equity awards as part of non-employee director compensation. She was granted 34,200 restricted stock units, each representing one future share of common stock, and 41,800 stock options with a $1.23 exercise price.
Both the RSUs and the options vest 100% on May 20, 2027 under the company’s 2023 Omnibus Incentive Plan. The options expire on May 20, 2036. These are compensation-related grants, not open‑market purchases or sales.
Insider Trade Summary
Grant/Award: 76,000 shares
Grant/Award
2 txns
Insider
Miller Ann Calby
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock Options | 41,800 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Unit | 34,200 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock Options — 41,800 contracts (Direct);
Restricted Stock Unit — 34,200 contracts (Direct)
Footnotes (3)
- F1. This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy.
- F2. Options to vest 100% on May 20, 2027.
- F3. Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027.
Key Figures
RSU grant: 34,200 units
Option grant: 41,800 options
Option exercise price: $1.23 per share
+5 more
8 metrics
RSU grant
34,200 units
Restricted stock units granted to director on May 20, 2026
Option grant
41,800 options
Common stock options granted to director on May 20, 2026
Option exercise price
$1.23 per share
Exercise price for 41,800 common stock options
RSU vesting date
May 20, 2027
RSUs vest 100% on this date
Option vesting date
May 20, 2027
Options vest 100% on this date
Option expiration
May 20, 2036
Expiration date of common stock options
RSUs held after grant
34,200 units
Total RSUs following transaction, direct ownership
Options held after grant
41,800 options
Total options following transaction, direct ownership
Key Terms
Restricted Stock Unit, 2023 Omnibus Incentive Plan, non-employee director compensation policy, Common Stock Options, +1 more
5 terms
Restricted Stock Unit financial
"Each restricted stock unit represents a contingent right to receive one share of common stock."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
2023 Omnibus Incentive Plan financial
"This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy."
non-employee director compensation policy financial
"This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy."
Common Stock Options financial
"Common Stock Options"
exercise price financial
"conversion_or_exercise_price: "1.2300""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did INO director Ann Calby Miller receive on this Form 4?
Ann Calby Miller received 34,200 restricted stock units and 41,800 stock options as director compensation. The RSUs convert into common shares at vesting, and the options give her the right to buy shares at a fixed exercise price.
What is the exercise price and expiration date of Ann Calby Miller’s INO stock options?
The stock options have a $1.23 per share exercise price and expire on May 20, 2036. This means she can choose to buy common shares at $1.23 any time after vesting and before the expiration date.
When do Ann Calby Miller’s INO restricted stock units and options vest?
Both the 34,200 restricted stock units and the 41,800 stock options vest 100% on May 20, 2027. Vesting means the awards become fully earned and exercisable or deliverable on that date if she remains eligible.
Are these INO Form 4 transactions open-market buys or sells?
No, these transactions are compensation-related grants, not open-market buys or sells. The Form 4 shows awards granted under Inovio’s 2023 Omnibus Incentive Plan and its non-employee director compensation policy, with no cash purchase or sale on the market.
Under which plan were Ann Calby Miller’s INO equity awards granted?
The equity awards were granted under Inovio’s 2023 Omnibus Incentive Plan. This plan governs stock-based compensation for eligible participants, including non-employee directors, and sets terms for grants like vesting schedules and award types.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates